IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease

Gastroenterology

Volumn 132, Issue 5, 2007, Pages 1657-1664

  Tremelling, Mark ^a,i   Cummings, Fraser ^b,c,i   Fisher, Sheila A ^d,i   Mansfield, John ^e,i   Gwilliam, Rhian ^f,i   Keniry, Andrew ^f,i   Nimmo, Elaine R ^g,i   Drummond, Hazel ^g,i   Onnie, Clive M ^h,i   Prescott, Natalie J ^h,i   Sanderson, Jeremy ^d,i   Bredin, Francesca ^a,i   Berzuini, Carlo ^a,i   Forbes, Alastair ^h,i   Lewis, Cathryn M ^d,i   Cardon, Lon ^c,i   Deloukas, Panos ^f,i   Jewell, Derek ^b,i   Mathew, Christopher G ^d,i   Parkes, Miles ^a,i   Satsangi, Jack ^g,i   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h GUY S HOSPITAL   (United Kingdom)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUTAMINE; INTERLEUKIN 23 RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

EID: 34247560627     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.02.051     Document Type: Article

References (37)

1. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nunez G., and Cho J.H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
2. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., and Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
3. Stone M.A., Mayberry J.F., and Baker R. Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England. Eur J Gastroenterol Hepatol 15 (2003) 1275-1280
4. Tysk C., Lindberg E., Jarnerot G., and Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29 (1988) 990-996
5. Reinhard C., and Rioux J.D. Role of the IBD5 susceptibility locus in the inflammatory bowel diseases. Inflamm Bowel Dis 12 (2006) 227-238
6. Yamazaki K., McGovern D., Ragoussis J., Paolucci M., Butler H., Jewell D., Cardon L., Takazoe M., Tanaka T., Ichimori T., Saito S., Sekine A., Iida A., Takahashi A., Tsunoda T., Lathrop M., and Nakamura Y. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 14 (2005) 3499-3506
7. Ho G.-T., Nimmo E.R., Tenesa A., Fennell J., Drummond H., Mowat C., Arnott I.D., and Satsangi J. Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. Gastroenterology 128 (2005) 288-296
8. Franchimont D., Vermeire S., El Housni H., Pierik M., Van Steen K., Gustot T., Quertinmont E., Abramowicz M., Van Gossum A., Deviere J., and Rutgeerts P. Deficient host-bacteria interactions in inflammatory bowel disease?. The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 53 (2004) 987-992
9. Stoll M., Corneliussen B., Costello C.M., Waetzig G.H., Mellgard B., Koch W.A., Rosenstiel P., Albrecht M., Croucher P.J., Seegert D., Nikolaus S., Hampe J., Lengauer T., Pierrou S., Foelsch U.R., Mathew C.G., Lagerstrom-Fermer M., and Schreiber S. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 36 (2004) 476-480
10. Cardon L.R., and Bell J.I. Association study designs for complex diseases. Nat Rev Genet 2 (2001) 91-99
11. Risch N., and Merikangas K. The future of genetic studies of complex human diseases. Science 273 (1996) 1516-1517
12. Barrett J.C., and Cardon L.R. Evaluating coverage of genome-wide association studies. Nat Genet 38 (2006) 659-662
13. Hirschhorn J.N., and Daly M.J. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6 (2005) 95-108
14. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., Steinhart A.H., Abraham C., Regueiro M., Griffiths A., Dassopoulos T., Bitton A., Yang H., Targan S., Datta L.W., Kistner E.O., Schumm L.P., Lee A., Gregersen P.K., Barmada M.M., Rotter J.I., Nicolae D.L., and Cho J.H. A Genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 (2006) 1461-1463
15. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170 (1989) 2-6
16. Power C., and Elliott J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int J Epidemiol 35 (2006) 34-41
17. Clayton D.G., Walker N.M., Smyth D.J., Pask R., Cooper J.D., Maier L.M., Smink L.J., Lam A.C., Ovington N.R., Stevens H.E., Nutland S., Howson J.M.M., Faham M., Moorhead M., Jones H.B., Falkowski M., Hardenbol P., Willis T.D., and Todd J.A. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat Genet 37 (2005) 1243-1246
18. Waller S., Tremelling M., Bredin F., Godfrey L., Howson J., and Parkes M. Evidence for association of OCTN genes and IBD5 with ulcerative colitis. Gut 55 (2006) 809-814
19. Pearce A.V., Fisher S.A., Prescott N.J., Onnie C.M., Pattni R., Green P., Forbes A., Mansfield J., Sanderson J., Schreiber S., Lewis C.M., and Mathew C.G. Investigation of association of the DLG5 gene with phenotypes of inflammatory bowel disease in the British population. Int J Colorectal Dis 22 (2007) 419-424
20. Arnott I.D., Nimmo E.R., Drummond H.E., Fennell J., Smith B.R., MacKinlay E., Morecroft J., Anderson N., Kelleher D., O'Sullivan M., McManus R., and Satsangi J. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?. Genes Immun 5 (2004) 417-425
21. Ahmad T., Tamboli C.P., Jewell D., and Colombel J.F. Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology 126 (2004) 1533-1549
22. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 19 (1955) 251-253
23. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
24. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25 (2003) 115-121
25. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., Caprilli R., Colombel J.F., Gasche C., Geboes K., Jewell D.P., Karban A., Loftus Jr. E.V., Pena A.S., Riddell R.H., Sachar D.B., Schreiber S., Steinhart A.H., Targan S.R., Vermeire S., and Warren B.F. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19 Suppl A (2005) 5-36
26. Economou M., Trikalinos T.A., Loizou K.T., Tsianos E.V., and Ioannidis J.P.A. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 99 (2004) 2393-2404
27. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., and Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33 (2003) 177-182
28. A haplotype map of the human genome 437 (2005), Nature 1299-1320
29. Zhang X., Zhang H., Zhang Y., Fu Y., He J., Zhu L., Wang S., and Liu L. Identification and expression analysis of alternatively spliced isoforms of human interleukin-23 receptor gene in normal lymphoid cells and selected tumor cells. Immunogenetics 57 (2006) 934-943
30. McKenzie B.S., Kastelein R.A., and Cua D.J. Understanding the IL-23-IL-17 immune pathway. Trends Immunol 27 (2006) 17-23
31. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., Zonin F., Vaisberg E., Churakova T., Liu M., Gorman D., Wagner J., Zurawski S., Liu Y., Abrams J.S., Moore K.W., Rennick D., de Waal-Malefyt R., Hannum C., Bazan J.F., and Kastelein R.A. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13 (2000) 715-725
32. Yen D., Cheung J., Scheerens H., Poulet F., McClanahan T., McKenzie B., Kleinschek M.A., Owyang A., Mattson J., Blumenschein W., Murphy E., Sathe M., Cua D.J., Kastelein R.A., and Rennick D. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116 (2006) 1310-1316
33. Hue S., Ahern P., Buonocore S., Kullberg M.C., Cua D.J., McKenzie B.S., Powrie F., and Maloy K.J. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 203 (2006) 2473-2483
34. Schmidt C., Giese T., Ludwig B., Mueller-Molaian I., Marth T., Zeuzem S., Meuer S.C., and Stallmach A. Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Inflamm Bowel Dis 11 (2005) 16-23
35. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., and Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
36. Edwards A.O., Ritter III R., Abel K.J., Manning A., Panhuysen C., and Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005) 421-424
37. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Noureddine M., Gilbert J.R., Schnetz-Boutaud N., Agarwal A., Postel E.A., and Pericak-Vance M.A. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005) 419-421